6-(Propan-2-yl)-3-methyl-morpholine-2,5-dione, a novel cyclodidepsipeptide with modulatory effect on rat thymocytes

被引:6
|
作者
Pavlovic, Voja [1 ]
Cherneva, Emiliya [2 ]
Yancheva, Denitsa [3 ]
Smelcerovic, Andrija [4 ]
机构
[1] Univ Nis, Fac Med, Inst Physiol, Nish 18000, Serbia
[2] Med Univ Sofia, Fac Pharm, Dept Chem, Sofia 1000, Bulgaria
[3] Bulgarian Acad Sci, Ctr Phytochem, Inst Organ Chem, BU-1113 Sofia, Bulgaria
[4] Univ Nis, Fac Med, Dept Chem, Nish 18000, Serbia
关键词
6-(Propan-2-yl)-3-methyl-morpholine-2,5-dione; Cyclodidepsipeptides; Thymocytes cytotoxicity; Oxidative stress; Mitochondrial membrane potential; CHIRAL 1,4-MORPHOLIN-2,5-DIONE DERIVATIVES; ALPHA-GLUCOSIDASE INHIBITORS; OXIDATIVE STRESS; ANTIMICROBIAL ACTIVITY; SANGLIFEHRIN-A; APOPTOSIS; CELLS; CYCLODEPSIPEPTIDES; PROLIFERATION; BINDING;
D O I
10.1016/j.fct.2012.06.004
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
A study has been carried out on the potential effect of a novel cyclodidepsipeptide, 6-(propan-2-yl)-3-methyl-morpholine-2,5-dione (PMMD), on rat thymocytes. Rat thymocytes were cultivated with increasing PMMD concentrations (0.1, 1, 10 mu g/well), for 24 h, and evaluated for proliferative activity, viability, reactive oxygen species and mitochondrial membrane potential. The higher PMMD concentrations inhibited thymocytes proliferative activity mainly through induction of oxidative stress and resulting cytotoxicity, without any mitochondrial membrane potential alterations in thymocytes. The obtained results are correlated with previously published data on effects of 6-(propan-2-yl)-4-methyl-morpholine-2,5-diones on rat thymocytes. The presence of methyl group in position 4 or/and the length of alkyl chain in position 3 of 6-(propan-2-yl)-morpholine-2,5-dione core plays a role for the obtained differences in the biological response between PMMD and two previously tested 6-(propan-2-yl)-4-methyl-morpholine-2,5-diones. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3014 / 3018
页数:5
相关论文
共 50 条
  • [21] New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones
    Kaminski, Krzysztof
    Zagaja, Miroslaw
    Rapacz, Anna
    Luszczki, Jarogniew J.
    Andres-Mach, Marta
    Abram, Michal
    Obniska, Jolanta
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (04) : 606 - 618
  • [22] Synthesis and Structure of 2-hydroxy-2-methyl-1,3-bis-(methyl 3′,4′,6′-tri-O-acetyl-β-D-glucopyranosid-2-yl)-imidazolidine-4,5-dione
    Temeriusz, A
    Rowinska, M
    Piekarska-Bartoszewicz, B
    Anulewicz-Ostrowska, R
    Cyranski, MK
    JOURNAL OF CARBOHYDRATE CHEMISTRY, 2005, 24 (07) : 697 - 704
  • [23] 2-{[(2-Methylprop-2-en-1-yl)oxy]methyl}-6-phenyl-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione
    El-Brollosy, Nasser R.
    El-Emam, Ali A.
    Al-Turkistani, Abdulghafoor A.
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2012, 68 : O347 - U149
  • [24] 6-(4-Amino-1-methyl-2-(methylthio)-6-oxo-1,6-dihydro-pyrimidin-5-yl)-3,6-dimethyl-2-(methylthio)-6,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-4,5-dione
    Romo, Pablo E.
    Quiroga, Jairo
    Insuasty, Braulio
    Nogueras, Manuel
    Cobo, Justo
    MOLBANK, 2015, (01)
  • [25] The crystal structure of 1,4-bis((1H-benzimidazol-2-yl)methyl)-piperazine-2,5-dione dihydrate, C20H22N6O4
    Jia, Aijun
    Gong, Zhihai
    Li, Ji
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2022, 237 (01): : 173 - 174
  • [26] Acridone-based inhibitors of inosine 5′-monophosphate dehydrogenase:: Discovery and SAR leading to the identification of N-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)
    Watterson, Scott H.
    Chen, Ping
    Zhao, Yufen
    Gu, Henry H.
    Dhar, T. G. Murali
    Xiao, Zili
    Ballentine, Shelley K.
    Shen, Zhongqi
    Fleener, Catherine A.
    Rouleau, Katherine A.
    Obermeier, Mary
    Yang, Zheng
    McIntyre, Kim W.
    Shuster, David J.
    Witmer, Mark
    Dambach, Donna
    Chao, Sam
    Mathur, Arvind
    Chen, Bang-Chi
    Barrish, Joel C.
    Robl, Jeffrey A.
    Townsend, Robert
    Iwanowicz, Edwin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (15) : 3730 - 3742
  • [27] 3-[(1Z)-1-hydroxy-3-oxobut-1-en-1-yl]-7-methyl-2H, 5H-pyrano[4,3-b] pyran-2,5-dione
    Bouhaine, N.
    Gherrou, A.
    van der Lee, A.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O5401 - O5403
  • [28] In vivo activity of a phospholipase C inhibitor, 1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions
    Hou, CF
    Kirchner, T
    Singer, M
    Matheis, M
    Argentieri, D
    Cavender, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02): : 697 - 704
  • [29] Synthesis, anti-microbial activity, and cytotoxicity of novel 1-[5-[6-[(2-benzoylbenzofuran-5-yl)methyl]-2-oxo-2H-chromen-3-yl]thiazol-2-yl]urea derivatives
    Bhookya Shankar
    Pochampally Jalapathi
    Modhumpuram Nagamani
    Bharath Gandu
    Karunakar Rao Kudle
    Monatshefte für Chemie - Chemical Monthly, 2017, 148 : 999 - 1009
  • [30] Synthesis, spectral characterization and biological evaluation of a novel series of 6-arylsubstituted-3-[2-(4-substitutedphenyl)propan-2-yl]-7H-[1,2,4]triazolo [3,4-b][1,3,4]thiadiazines
    Puthiyapurayil, Pushpan
    Poojary, Boja
    Chikkanna, Chandrashekhar
    Buridipad, Sunil Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 57 : 407 - 416